A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma

Elizabeth K. O'Donnell, Jacob P. Laubach, Andrew J. Yee, Tianqi Chen, Carol Ann Huff, Frank G. Basile, Philip M. Wade, Claudia E. Paba-Prada, Irene M. Ghobrial, Robert L. Schlossman, Jill N. Burke, Cynthia C. Harrington, Kathleen J. Lively, Hannah F. Lyons, Nikhil C. Munshi, Kenneth C. Anderson, Lorenzo Trippa, Paul G. Richardson, Noopur S. Raje